Change search
ReferencesLink to record
Permanent link

Direct link
Structures of type B ribose 5-phosphate isomerase from Trypanosoma cruzi shed light on the determinants of sugar specificity in the structural family
Uppsala University, Disciplinary Domain of Science and Technology, Biology, Department of Cell and Molecular Biology, Structure and Molecular Biology.
2011 (English)In: The FEBS Journal, ISSN 1742-464X, E-ISSN 1742-4658, Vol. 278, no 5, 793-808 p.Article in journal (Refereed) Published
Abstract [en]

Ribose-5-phosphate isomerase (Rpi; EC 5.3.1.6) is a key activity of the pentose phosphate pathway. Two unrelated types of sequence/structure possess this activity: type A Rpi (present in most organisms) and type B Rpi (RpiB) (in some bacteria and parasitic protozoa). In the present study, we report enzyme kinetics and crystallographic studies of the RpiB from the human pathogen, Trypanosoma cruzi. Structures of the wild-type and a Cys69Ala mutant enzyme, alone or bound to phosphate, D-ribose 5-phosphate, or the inhibitors 4-phospho-D-erythronohydroxamic acid and D-allose 6-phosphate, highlight features of the active site, and show that small conformational changes are linked to binding. Kinetic studies confirm that, similar to the RpiB from Mycobacterium tuberculosis, the T. cruzi enzyme can isomerize D-ribose 5-phosphate effectively, but not the 6-carbon sugar D-allose 6-phosphate; instead, this sugar acts as an inhibitor of both enzymes. The behaviour is distinct from that of the more closely related (to T. cruzi RpiB) Escherichia coli enzyme, which can isomerize both types of sugars. The hypothesis that differences in a phosphate-binding loop near the active site were linked to the differences in specificity was tested by construction of a mutant T. cruzi enzyme with a sequence in this loop more similar to that of E. coli RpiB; this mutant enzyme gained the ability to act on the 6-carbon sugar. The combined information allows us to distinguish the two types of specificity patterns in other available sequences. The results obtained in the present study provide insights into the action of RpiB enzymes generally, and also comprise a firm basis for future work in drug design.

Place, publisher, year, edition, pages
2011. Vol. 278, no 5, 793-808 p.
Keyword [en]
Chagas disease, enzyme specificity, pentose phosphate pathway, type B ribose 5-phosphate isomerase (RpiB), X-ray crystallography
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-148963DOI: 10.1111/j.1742-4658.2010.07999.xISI: 000287448800010OAI: oai:DiVA.org:uu-148963DiVA: diva2:403538
Funder
Swedish Research Council
Available from: 2011-04-26 Created: 2011-03-14 Last updated: 2012-09-18Bibliographically approved

Open Access in DiVA

FULLTEXT(2794 kB)167 downloads
File information
File name FULLTEXT02.pdfFile size 2794 kBChecksum SHA-512
b4a68c44671e72bec4c22e7c90bb0d340463014db68eb80201a9f23c1ec0991f4c112abb34b03907c5a531a8e6650c4658f491e6ff261ee60d585d7ceb72ca72
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Mowbray, Sherry L.
By organisation
Structure and Molecular Biology
In the same journal
The FEBS Journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 167 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 209 hits
ReferencesLink to record
Permanent link

Direct link